ADX-324 clinical trials

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

This study is looking at a new medicine called ADX-324 for people with Hereditary Angioedema (HAE) Type 1 or 2. It will check if the medicine helps prevent HAE attacks and if it is safe. Researchers will also look at how it affects quality of life.